Department of Liver Surgery & Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
BMC Surg. 2022 May 18;22(1):193. doi: 10.1186/s12893-022-01643-7.
Previous studies have reported the surgical resection (SR) and radiofrequency ablation (RFA) could achieve comparable recurrence-to-death survival (RTDS). However, the impact of primary tumor burden on RTDS of patients with recurrent hepatocellular carcinoma (HCC) following SR or RFA has not been clarified.
From January 2009 to March 2015, 171 patients who underwent initial hepatectomy and second curative treatments in West China Hospital were retrospectively analyzed. Survival analysis was performed by the Kaplan-Meier method. Risk factors were identified using the Cox proportional hazard model.
At initial hepatectomy, 96 patients (56.1%) were diagnosed with HCC within the Milan criteria (MC), and 75 patients (43.9%) were HCC beyond the MC. The clinicopathological features and re-treatment methods of recurrent HCC were similar between patients with primary HCC within or beyond the MC. Patients with primary HCC within the MC had longer recurrence time (31.4 ± 24.2 months vs. 20.2 ± 16 months, P < 0.001). The 1- and 3- year RTDS within and beyond the MC group were 88.8%, 57.6% and 79.0%, 46.3%, respectively (P = 0.093). In multivariate analysis, the recurrence time, tumor size and AFP > 400 ng/mL at the time of recurrence were associated with RTDS.
The primary tumor burden had no impact on RTDS, but had an impact on recurrence time. The recurrence time had an impact on RTDS and might be a good index to reflect the biology of recurrent HCC.
先前的研究报告称,手术切除 (SR) 和射频消融 (RFA) 可实现可比的复发至死亡生存 (RTDS)。然而,原发性肿瘤负担对 SR 或 RFA 后复发性肝细胞癌 (HCC)患者的 RTDS 的影响尚未阐明。
从 2009 年 1 月至 2015 年 3 月,回顾性分析了在华西医院接受初始肝切除术和第二次治愈性治疗的 171 例患者。采用 Kaplan-Meier 法进行生存分析。使用 Cox 比例风险模型确定危险因素。
在初始肝切除时,96 例患者 (56.1%) 被诊断为米兰标准 (MC) 内的 HCC,75 例患者 (43.9%) 为 MC 外的 HCC。MC 内或 MC 外原发性 HCC 患者的复发 HCC 的临床病理特征和再治疗方法相似。MC 内原发性 HCC 患者的复发时间更长 (31.4±24.2 个月比 20.2±16 个月,P<0.001)。MC 内和 MC 外组的 1 年和 3 年 RTDS 分别为 88.8%、57.6%和 79.0%、46.3%(P=0.093)。多因素分析显示,复发时间、肿瘤大小和复发时 AFP>400ng/mL 与 RTDS 相关。
原发性肿瘤负担对 RTDS 没有影响,但对复发时间有影响。复发时间对 RTDS 有影响,可能是反映复发性 HCC 生物学特性的一个良好指标。